CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.

For much of the past few years, CVS was treated as a problem stock. But new earnings show a promised comeback is actually ...

CVS Health had another solid quarter. The company, which is emerging from a yearslong turnaround, reported an 8% increase in ...

Medicare Advantage rates may not be going up as much as expected in 2027, and that has investors concerned about CVS Health.

Recent Medicare Advantage news may mean disappointing updates to guidance.

CVS Q4 earnings preview: analysts see profit down 16% as revenue rises. Learn EPS/revenue forecasts, revisions, and outlook—read before Feb.

CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

The healthcare giant outperformed to close out 2025, and expects its finances to improve further this year. Still, proposed ...

CVS Health Corporation (NYSE:CVS) is one of the best cheap stocks to buy for 2026. On January 27, BofA Securities cut its ...

CVS Health Corporation (NYSE:CVS) is included among 12 Unstoppable Dividend Stocks to Buy According to Analysts. On January ...

Shares of CVS Health were headed for their best day in more than five months as all of its business segments saw double-digit percentage revenue growth Shares of CVS Health Corp. shot higher in early ...